Literature DB >> 31863093

Hypothyroidism, Sex, and Age Predict Future Thromboembolic Events Among Younger People.

Jay A Martinez1, Fares Qeadan2, Mark R Burge1.   

Abstract

PURPOSE: Aberrant thyroid function causes dysregulated metabolic homeostasis. Literature has demonstrated hypercoagulability in hypothyroidism, suggesting a risk for thromboembolic events (TEE). We hypothesize that individuals with hypothyroidism will experience more clinically-diagnosed TEE than euthyroid individuals.
METHODS: De-identified patient data from the University of New Mexico Health Sciences Center were retrieved using thyrotropin (TSH; thyroid-stimulating hormone) for case-finding from 2005 to 2007 and ICD billing codes to identify TEE during the follow-up period of 10 to 12 years. Diagnoses affecting coagulation were excluded and 12 109 unique enrollees were categorized according to TSH concentration as Hyperthyroid (n = 510), Euthyroid (n = 9867), Subclinical Hypothyroid (n = 1405), or Overtly Hypothyroid (n = 327). Analysis with multiple logistic regression provided the odds of TEE while adjusting for covariates.
RESULTS: There were 228 TEEs in the cohort over 5.1 ± 4.3 years of follow-up. Risk of TEE varied significantly across study groups while adjusting for sex, race/ethnicity, levothyroxine, oral contraceptive therapy, and visit status (outpatient vs non-outpatient), and this risk was modified by age. Overt Hypothyroidism conferred a significantly higher risk of TEE than Euthyroidism below age 35, and Hyperthyroidism conferred an increased risk for TEE at age 20. Analysis also demonstrated a higher age-controlled risk for a subsequent TEE in men compared with women (odds ratio [OR] = 1.36; 95% confidence interval [CI], 1.02-1.81). Subanalysis of smoking status (n = 5068, 86 TEE) demonstrated that smokers have 2.21-fold higher odds of TEE relative to nonsmokers (95% CI, 1.41-3.45).
CONCLUSIONS: In this retrospective cohort study, Overt Hypothyroidism conferred increased risk of TEE over the next decade for individuals younger than 35 years of age, as compared with Euthyroidism. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Hypothyroidism; euthyroid; hyperthyroidism; subclinical hypothyroidism; thromboembolic events

Year:  2020        PMID: 31863093      PMCID: PMC7174050          DOI: 10.1210/clinem/dgz291

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

Review 1.  Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity.

Authors:  Olga L Quintero; Manuel J Amador-Patarroyo; Gladys Montoya-Ortiz; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2011-11-12       Impact factor: 7.094

2.  Fibrin clot structure and fibrinolysis in hypothyroid individuals: the effects of normalising thyroid hormone levels.

Authors:  D J F Stuijver; J M W Hooper; S M Orme; B Van Zaane; A Squizzato; E Piantanida; K Hess; S Alzahrani; R A Ajjan
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

3.  Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel.

Authors:  Donald S A McLeod; Patrizio Caturegli; David S Cooper; Peter G Matos; Susan Hutfless
Journal:  JAMA       Date:  2014-04-16       Impact factor: 56.272

Review 4.  Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed - A Review for Primary Care.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2016-05-26

5.  Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy.

Authors:  John Yango; Orsalia Alexopoulou; Stephane Eeckhoudt; Cedric Hermans; Chantal Daumerie
Journal:  Eur J Endocrinol       Date:  2011-01-21       Impact factor: 6.664

6.  Reference values for thrombotic markers in children.

Authors:  Darintr Sosothikul; Yaowaree Kittikalayawong; Pattramon Aungbamnet; Chatchai Buphachat; Panya Seksarn
Journal:  Blood Coagul Fibrinolysis       Date:  2012-04       Impact factor: 1.276

7.  History of thyroid disorders in relation to clinical outcomes in atrial fibrillation.

Authors:  Helene Bruere; Laurent Fauchier; Anne Bernard Brunet; Bertrand Pierre; Edouard Simeon; Dominique Babuty; Nicolas Clementy
Journal:  Am J Med       Date:  2014-07-21       Impact factor: 4.965

8.  Venous thromboembolism in patients hospitalized with thyroid dysfunction.

Authors:  Liviu G Danescu; Aaref Badshah; Septimiu C Danescu; Muhammad Janjua; Anna M Marandici; Fadi Matta; Abdo Y Yaekoub; Dennis J Malloy; Paul D Stein
Journal:  Clin Appl Thromb Hemost       Date:  2009-08-10       Impact factor: 2.389

9.  Hypothyroidism, Sex, and Age Predict Future Thromboembolic Events Among Younger People.

Authors:  Jay A Martinez; Fares Qeadan; Mark R Burge
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

10.  Central hypothyroidism.

Authors:  Vishal Gupta; Marilyn Lee
Journal:  Indian J Endocrinol Metab       Date:  2011-07
View more
  4 in total

1.  Hypothyroidism, Sex, and Age Predict Future Thromboembolic Events Among Younger People.

Authors:  Jay A Martinez; Fares Qeadan; Mark R Burge
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

2.  Expression patterns of serum MicroRNAs related to endothelial dysfunction in patients with subclinical hypothyroidism.

Authors:  Xuelin Yao; Ying Wang; Li Wang; Mingfeng Cao; Aifang Chen; Xinhuan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

3.  Thyroid Hormone Therapy and Incident Stroke.

Authors:  Maria Papaleontiou; Deborah A Levine; David Reyes-Gastelum; Sarah T Hawley; Mousumi Banerjee; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

4.  Association between SSNHL and Thyroid Diseases.

Authors:  So Young Kim; Young Shin Song; Jee Hye Wee; Chanyang Min; Dae Myoung Yoo; Hyo Geun Choi
Journal:  Int J Environ Res Public Health       Date:  2020-11-13       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.